Quantbot Technologies’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-210
Closed -$34K – 1577
2021
Q3
$34K Buy
210
+180
+600% +$29.2K ﹤0.01% 1173
2021
Q2
$4K Buy
+30
New +$5.06K ﹤0.01% 1376
2020
Q3
– Sell
-61
Closed -$12K – 1346
2020
Q2
$12K Buy
+61
New +$11.2K ﹤0.01% 896

Other funds holding CTSO

Quantbot Technologies's CTSO Position: Q4 2021 in Review

Quantbot Technologies sold out of Cytosorbents (CTSO) in Q4 2021, closing a stake of 210 shares — an estimated $34K sold.

Quantbot Technologies first reported a position in CTSO in Q2 2020 and held it in 3 quarters. The position peaked at $34K in Q3 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • Quantbot Technologies reported no remaining Cytosorbents position as of Q4 2021 after selling out during the quarter.
  • Quantbot Technologies sold 210 Cytosorbents shares in Q4 2021, an estimated $34K.
  • Quantbot Technologies first reported a position in Cytosorbents in Q2 2020 and held it in 3 quarters.
  • Quantbot Technologies's Cytosorbents position peaked at $34K in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Cytosorbents as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.